MedTrace Logo

Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study

NCT02789176 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 303

Last updated 2020-12-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine whether the duration of treatment with phenobarbital has an impact on neurodevelopmental and epilepsy outcomes, as well as parent and family well-being, after neonatal seizures.

Conditions

  • Neonatal Seizures

Interventions

OTHER

Surveys

Regarding development, epilepsy, and family impact

OTHER

EEG

Sponsors & Collaborators

Principal Investigators

  • Renée A Shellhaas, MD, MS · University of Michigan

  • Hannah C Glass, MDCM, MAS · University of California, San Francisco

Eligibility

Min Age
0 Weeks
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2020-03-24
Completion
2020-03-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02789176 on ClinicalTrials.gov